Sign in

CIK 0001819790 · Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
814717861
Phone
(949) 409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Open-market sale Chief Medical Officer sold 2,078 shares at $79.50 ($165,201)
  2. 4 Gift President/CEO and Board Chair gave 51,885 shares (gift)
  3. 4 Planned sale President/CEO and Board Chair sold 6,000 shares at $55.37 ($332,220)
  4. 4 Gift Director gave 2,000 shares (gift)
  5. 4 Option exercise Director acquired 1,334 shares (option exercise)
  6. 4 Open-market sale Director sold 27,116 shares at $57.00 ($1,545,612)
  7. 4 Planned sale President/CEO and Board Chair sold 6,000 shares at $50.00 ($300,000)
  8. 4 Open-market sale See Remarks sold 13,608 shares at $40.42 ($550,035)
  9. 4 Open-market sale Chief Medical Officer sold 1,006 shares at $41.08 ($41,326)
  10. 4 Option exercise Director acquired 3,350 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Option exercise Director acquired 3,350 shares (option exercise)
  13. 4 Option exercise Director acquired 3,350 shares (option exercise)
  14. 4 Option exercise Director acquired 3,350 shares (option exercise)
  15. 4 Option exercise Director acquired 3,350 shares (option exercise)
  16. 4 Planned sale Chief Commercial Officer sold 17,500 shares at $43.76 ($765,800)
  17. 4 Open-market sale President/CEO and Board Chair sold 6,000 shares at $50.00 ($300,000)
  18. 4 Open-market sale Chief Commercial Officer sold 10,565 shares at an average $47.88 ($505,856)
  19. 4 Open-market sale Chief Operating Officer sold 7,583 shares at an average $47.89 ($363,142)
  20. 4 Open-market sale General Counsel sold 9,686 shares at an average $47.88 ($463,766)

Page 4 of 17 · 330 filings